Tendersinfo keep you informed about the latest events in the national and international Procurement Industry. Procurement News provides in-depth coverage of the procurement industry, including contract awards, contract additions, new contract wins, mergers and acquisitions. Tendersinfo through its tender news section provides an update on all domestic and global tendering opportunities, invitation to bid & trade leads.

Publish Date : 16-Feb-2015

The Global Fund ARV Tender has granted a deal Cipla to render anti-AIDS medicines, valued at approx. $188.95 million. As per Cipla , deal is effective January 1, 2015 and will run for a period of three years and from the 4Q the financial year 2015, the supplies will commence.

Subhanu Saxena, Cipla’s Managing Director and Global Chief Executive, said in a statement: “We are extremely proud to have won this tender from Global Fund. Cipla has been committed to the cause of HIV/AIDS for over two decades and this tender offers us a great opportunity to make HIV/AIDS treatment accessible to more than 140 countries through Global Fund.”

Moreover, at Cipla’s manufacturing facilities in India, anti-retrovirals (ARV) drugs will be manufactured, as per the several international regulatory agencies green nod.

Go to previous page